Hutchison China Meditech Ltd (LSE:HCM) - Share price - Overview


Stock Report

Hutchison China Meditech Ltd HCM

Last Price
GBX4,510.00

Day Change
35.00|0.78%

As of 22/03/2019
15:42:36 GMT | GBX
Minimum 15 Minutes Delay.

Last Close4,475.00p
Day Range4,400.00 - 4,550.00
Mkt Cap3.01Bil
52-Wk Range3,180.00 - 5,600.00
Yield %-
ISINKYG4672N1016
Volume4,956
P/E-3,991.15
P/S13.99
P/CF-91.30

Share Price

Total Returns 22/03/2019

 Chg (%)  
More ...
Hutchison China Meditech Ltd18.68 
FTSE 100 TR GBP0.93
 
Financials
201620172018
More ...
Income Statement
Turnover216.08241.20214.11
Operating Profit-46.70-53.42-92.64
Net Profit14.56-22.96-71.29
Reported EPS0.20-0.43-1.13
Balance Sheet
Current Assets167.38432.20370.54
Non Current Assets175.06165.74161.58
Total Assets342.44597.93532.12
Current Liabilities95.12104.6085.48
Total Liabilities---
Total Equity204.06484.97412.26
Cash Flow
Operating Cash Flow-9.57-8.94-32.85
Net Change in Cash49.273.472.67

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
27/03/2018Transfer inChristian Hogg0.004,4700.00
27/03/2018Transfer inJohnny Cheng Chig FUNG0.001,3780.00
27/03/2018Transfer inDr. Weiguo Su0.001,6320.00

Company Profile

Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms--an innovation platform and a commercial platform aimed at discovering and developing therapeutics in oncology and autoimmune diseases.

Sector

Drug Manufacturers - Major

Index

FTSE AIM 100 ,FTSE AIM All-Share

Next Event 24/04/2019

Annual General Meeting
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-19.18
Op Mrgn-0.43
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Executive OfficerChristian Hogg
Executive Director, Chief Financial OfficerJohnny Cheng Chig FUNG
Executive Director, Chief Scientific OfficerDr. Weiguo Su
Non-Executive DirectorMr. Graeme Allan Jack
Non-Executive DirectorDan Eldar
Non-Executive DirectorMr Paul Rutherford Carter
Non-Executive DirectorProfessor Shu Kam Tony Mok
Non-Executive DirectorDr. Karen Jean Ferrante M.D.
Non-Executive Director, Company SecretaryEdith Shih
Executive Director, ChairmanSimon To
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.